drugset / Trial / NCT01120106

Levosimendan Administration in Neonates With Transposition of the Great Arteries

NCT01120106

Phase 2 Completed 63 enrolled Bambino Gesù Hospital and Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

Calcium sensitizer drugs such as Levosimendan may exert anti-ischemic effect in addition to positive inotropic and anti-stunning effects mediated by the opening of ATP-sensitive potassium (KATP) channels. The aim of the study is to test the myocardial protection effect of peri-operative iv infusion of Levosimendan in a cohort of neonates affected by transposition of the great arteries undergoing surgical correction by arterial switch.

Timeline

Start
2009-01
Primary completion
2010-12
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levosimendan Other / unclassified 0.1 ug/kg Intravenous

Indications

No indication recorded.